Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Tamura, SY; Weinhouse, MI; Roberts, CA; Goldman, EA; Masukawa, K; Anderson, SM; Cohen, CR; Bradbury, AE; Bernardino, VT; Dixon, SA; Ma, MG; Nolan, TG; Brunck, TK
   Synthesis and biological activity of peptidyl aldehyde urokinase inhibitors
   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
   
   S.Y. Tamura et al., "Synthesis and biological activity of peptidyl aldehyde urokinase inhibitors", BIOORG MED, 10(9), 2000, pp. 983-987
2. Tamura, SY; Levy, OE; Uong, TH; Reiner, JE; Goldman, EA; Ho, JZ; Cohen, CR; Bergum, PW; Nutt, RF; Brunck, TK; Semple, JE
   Guanylpiperidine peptidomimetics: Potent and selective bis-cation inhibitors of factor Xa
   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
   
   S.Y. Tamura et al., "Guanylpiperidine peptidomimetics: Potent and selective bis-cation inhibitors of factor Xa", BIOORG MED, 10(8), 2000, pp. 745-749
3. Reiner, JE; Lim-Wilby, MS; Brunck, TK; Ha-Uong, T; Goldman, EA; Abelman, MA; Nutt, RF; Semple, JE; Tamura, SY
   Investigation of the S-3 site of thrombin: Design, synthesis and biological activity of 4-substituted 3-amino-2-pyridones incorporating P-1-argininals
   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
   
   J.E. Reiner et al., "Investigation of the S-3 site of thrombin: Design, synthesis and biological activity of 4-substituted 3-amino-2-pyridones incorporating P-1-argininals", BIOORG MED, 9(6), 1999, pp. 895-900
4. Tamura, SY; Goldman, EA; Bergum, PW; Semple, JE
   Novel benzo-fused lactam scaffolds as factor Xa inhibitors
   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
   
   S.Y. Tamura et al., "Novel benzo-fused lactam scaffolds as factor Xa inhibitors", BIOORG MED, 9(17), 1999, pp. 2573-2578
5. TAMURA SY; GOLDMAN EA; BRUNCK TK; RIPKA WC; SEMPLE JE
   RATIONAL DESIGN, SYNTHESIS, AND SERINE-PROTEASE INHIBITORY ACTIVITY OF A NOVEL P-1-ARGININAL DERIVATIVE FEATURING A CONFORMATIONALLY CONSTRAINED P-2-P-3-BICYCLIC LACTAM MOIETY
   Bioorganic & medicinal chemistry letters
   
   S.Y. Tamura et al., "RATIONAL DESIGN, SYNTHESIS, AND SERINE-PROTEASE INHIBITORY ACTIVITY OF A NOVEL P-1-ARGININAL DERIVATIVE FEATURING A CONFORMATIONALLY CONSTRAINED P-2-P-3-BICYCLIC LACTAM MOIETY", Bioorganic & medicinal chemistry letters, 7(3), 1997, pp. 331-336
6. SEMPLE JE; MINAMI NK; TAMURA SY; BRUNCK TK; NUTT RF; RIPKA WC
   RATIONAL DESIGN AND SYNTHESIS OF A NOVEL, SELECTIVE CLASS OF THROMBININHIBITORS - P-1-ARGININAL DERIVATIVES INCORPORATING P-3-P-4 QUATERNARY LACTAM DIPEPTIDE SURROGATES
   Bioorganic & medicinal chemistry letters
   
   J.E. Semple et al., "RATIONAL DESIGN AND SYNTHESIS OF A NOVEL, SELECTIVE CLASS OF THROMBININHIBITORS - P-1-ARGININAL DERIVATIVES INCORPORATING P-3-P-4 QUATERNARY LACTAM DIPEPTIDE SURROGATES", Bioorganic & medicinal chemistry letters, 7(18), 1997, pp. 2421-2426
7. TAMURA SY; SEMPLE JE; REINER JE; GOLDMAN EA; BRUNCK TK; LIMWILBY MS; CARPENTER SH; ROTE WE; OLDESHULTE GL; RICHARD BM; NUTT RF; RIPKA WC
   DESIGN AND SYNTHESIS OF A NOVEL CLASS OF THROMBIN INHIBITORS INCORPORATING HETEROCYCLIC DIPEPTIDE SURROGATES
   Bioorganic & medicinal chemistry letters
   
   S.Y. Tamura et al., "DESIGN AND SYNTHESIS OF A NOVEL CLASS OF THROMBIN INHIBITORS INCORPORATING HETEROCYCLIC DIPEPTIDE SURROGATES", Bioorganic & medicinal chemistry letters, 7(12), 1997, pp. 1543-1548
8. TAMURA SY; SHAMBLIN BM; BRUNCK TK; RIPKA WC
   RATIONAL DESIGN, SYNTHESIS, AND SERINE-PROTEASE INHIBITORY ACTIVITY OF NOVEL P-1-ARGININOYL HETEROCYCLES
   Bioorganic & medicinal chemistry letters
   
   S.Y. Tamura et al., "RATIONAL DESIGN, SYNTHESIS, AND SERINE-PROTEASE INHIBITORY ACTIVITY OF NOVEL P-1-ARGININOYL HETEROCYCLES", Bioorganic & medicinal chemistry letters, 7(10), 1997, pp. 1359-1364
9. SEMPLE JE; ROWLEY DC; BRUNCK TK; HAUONG T; MINAMI NK; OWENS TD; TAMURA SY; GOLDMAN EA; SIEV DV; ARDECKY RJ; CARPENTER SH; GE Y; RICHARD BM; NOLAN TG; HAKANSON K; TULINSKY A; NUTT RF; RIPKA WC
   DESIGN, SYNTHESIS, AND EVOLUTION OF A NOVEL, SELECTIVE, AND ORALLY BIOAVAILABLE CLASS OF THROMBIN INHIBITORS - P1-ARGININAL DERIVATIVES INCORPORATING P3-P4 LACTAM SULFONAMIDE MOIETIES
   Journal of medicinal chemistry
   
   J.E. Semple et al., "DESIGN, SYNTHESIS, AND EVOLUTION OF A NOVEL, SELECTIVE, AND ORALLY BIOAVAILABLE CLASS OF THROMBIN INHIBITORS - P1-ARGININAL DERIVATIVES INCORPORATING P3-P4 LACTAM SULFONAMIDE MOIETIES", Journal of medicinal chemistry, 39(23), 1996, pp. 4531-4536
10. ROTE WE; DEMPSEY EM; OLDESCHULTE GL; ARDECKY RJ; TAMURA SY; NUTT RF; BERGUM PW; TRAN HS; ANDERSON SM; VLASUK GP
    EVALUATION OF A NOVEL ORALLY-ACTIVE DIRECT INHIBITOR OF THROMBIN IN ANIMAL-MODELS OF THROMBOSIS
    Circulation
    
    W.E. Rote et al., "EVALUATION OF A NOVEL ORALLY-ACTIVE DIRECT INHIBITOR OF THROMBIN IN ANIMAL-MODELS OF THROMBOSIS", Circulation, 90(4), 1994, pp. 344-344
11. ROTE WE; DEMPSEY EM; OLDESCHULTE GL; ARDECKY RJ; TAMURA SY; NUTT RF; BERGUM PW; TRAN HS; ANDERSON SM; VLASUK GP
    EVALUATION OF A NOVEL ORALLY-ACTIVE DIRECT INHIBITOR OF THROMBIN IN ANIMAL-MODELS OF THROMBOSIS
    Circulation
    
    W.E. Rote et al., "EVALUATION OF A NOVEL ORALLY-ACTIVE DIRECT INHIBITOR OF THROMBIN IN ANIMAL-MODELS OF THROMBOSIS", Circulation, 90(4), 1994, pp. 344-344